Discovery of 6-[(3S,4S)-4-Amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-3-(2,3-dichlorophenyl)-2-m

Czako, Barbara; Sun, Yuting; McAfoos, Timothy; Cross, Jason B.; Leonard, Paul G.; Burke, Jason P.; Carroll, Christopher L.; Feng, Ningping; Harris, Angela L.; Jiang, Yongying; Kang, Zhijun; Kovacs, Jeffrey J.; Mandal, Pijus; Meyers, Brooke A.; Mseeh, Faika; Parker, Connor A.; Yu, Simon S.; Williams, Christopher C.; Wu, Qi; Di Francesco, Maria Emilia; Draetta, Giulio; Heffernan, Timothy; Marszalek, Joseph.R.; Kohl, Nancy E.; Jones, Philip

doi:10.1021/acs.jmedchem.1c01132

Discovery of 6-[(3S,4S)-4-Amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-3-(2,3-dichlorophenyl)-2-m

Journal Article · Fri Oct 01 00:00:00 EDT 2021 · J. Med. Chem.

DOI:https://doi.org/10.1021/acs.jmedchem.1c01132· OSTI ID:1832569

Czako, Barbara; Sun, Yuting; McAfoos, Timothy; Cross, Jason B.; Leonard, Paul G.; Burke, Jason P.; Carroll, Christopher L.; Feng, Ningping; Harris, Angela L.; Jiang, Yongying; Kang, Zhijun; Kovacs, Jeffrey J.; Mandal, Pijus; Meyers, Brooke A.; Mseeh, Faika; Parker, Connor A.; Yu, Simon S.; Williams, Christopher C.; Wu, Qi; Di Francesco, Maria Emilia more »

Research Organization:: Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)

Sponsoring Organization:: DOE - Office Of Science; UNIVERSITY

OSTI ID:: 1832569

Journal Information:: J. Med. Chem., Journal Name: J. Med. Chem. Journal Issue: (20) Vol. 64

Country of Publication:: United States

Language:: ENGLISH

References (30)

Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia Tartaglia, Marco; Niemeyer, Charlotte M.; Fragale, Alessandra Nature Genetics, Vol. 34, Issue 2 https://doi.org/10.1038/ng1156	journal	April 2003
SHP2 forecast for the immune system: fog gradually clearing Salmond, Robert J.; Alexander, Denis R. Trends in Immunology, Vol. 27, Issue 3 https://doi.org/10.1016/j.it.2006.01.007	journal	March 2006
Rational design of allosteric-inhibition sites in classical protein tyrosine phosphatases Chio, Cynthia M.; Yu, Xiaoling; Bishop, Anthony C. Bioorganic & Medicinal Chemistry, Vol. 23, Issue 12 https://doi.org/10.1016/j.bmc.2015.03.027	journal	June 2015
SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivo Mainardi, Sara; Mulero-Sánchez, Antonio; Prahallad, Anirudh Nature Medicine, Vol. 24, Issue 7 https://doi.org/10.1038/s41591-018-0023-9	journal	May 2018
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases Chen, Ying-Nan P.; LaMarche, Matthew J.; Chan, Ho Man Nature, Vol. 535, Issue 7610 https://doi.org/10.1038/nature18621	journal	June 2016
Dual Allosteric Inhibition of SHP2 Phosphatase Fodor, Michelle; Price, Edmund; Wang, Ping ACS Chemical Biology, Vol. 13, Issue 3 https://doi.org/10.1021/acschembio.7b00980	journal	January 2018
Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase Ruess, Dietrich A.; Heynen, Guus J.; Ciecielski, Katrin J. Nature Medicine, Vol. 24, Issue 7 https://doi.org/10.1038/s41591-018-0024-8	journal	May 2018
RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1- and RAS-driven cancers Nichols, Robert J.; Haderk, Franziska; Stahlhut, Carlos Nature Cell Biology, Vol. 20, Issue 9 https://doi.org/10.1038/s41556-018-0169-1	journal	August 2018
6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 Inhibitors Sarver, Patrick; Acker, Michael; Bagdanoff, Jeffrey T. Journal of Medicinal Chemistry, Vol. 62, Issue 4 https://doi.org/10.1021/acs.jmedchem.8b01726	journal	January 2019
Identification of an allosteric benzothiazolopyrimidone inhibitor of the oncogenic protein tyrosine phosphatase SHP2 LaRochelle, Jonathan R.; Fodor, Michelle; Ellegast, Jana M. Bioorganic & Medicinal Chemistry, Vol. 25, Issue 24 https://doi.org/10.1016/j.bmc.2017.10.025	journal	December 2017
Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor Garcia Fortanet, Jorge; Chen, Christine Hiu-Tung; Chen, Ying-Nan P. Journal of Medicinal Chemistry, Vol. 59, Issue 17 https://doi.org/10.1021/acs.jmedchem.6b00680	journal	July 2016
Recent Advances of SHP2 Inhibitors in Cancer Therapy: Current Development and Clinical Application Yuan, Xinrui; Bu, Hong; Zhou, Jinpei Journal of Medicinal Chemistry, Vol. 63, Issue 20 https://doi.org/10.1021/acs.jmedchem.0c00249	journal	May 2020
Myeloid-Specific Disruption of Tyrosine Phosphatase Shp2 Promotes Alternative Activation of Macrophages and Predisposes Mice to Pulmonary Fibrosis Tao, Bo; Jin, Wei; Xu, Jiaqi The Journal of Immunology, Vol. 193, Issue 6 https://doi.org/10.4049/jimmunol.1303463	journal	August 2014
SHP2 Inhibition Prevents Adaptive Resistance to MEK Inhibitors in Multiple Cancer Models Fedele, Carmine; Ran, Hao; Diskin, Brian Cancer Discovery, Vol. 8, Issue 10 https://doi.org/10.1158/2159-8290.cd-18-0444	journal	July 2018
Leukemogenic Ptpn11 causes fatal myeloproliferative disorder via cell-autonomous effects on multiple stages of hematopoiesis Chan, Gordon; Kalaitzidis, Demetrios; Usenko, Tatiana Blood, Vol. 113, Issue 18 https://doi.org/10.1182/blood-2008-10-182626	journal	April 2009
Allosteric Inhibition of SHP2 Stimulates Antitumor Immunity by Transforming the Immunosuppressive Environment Quintana, Elsa; Schulze, Christopher J.; Myers, Darienne R. Cancer Research, Vol. 80, Issue 13 https://doi.org/10.1158/0008-5472.can-19-3038	journal	April 2020
Allosteric Wip1 phosphatase inhibition through flap-subdomain interaction Gilmartin, Aidan G.; Faitg, Thomas H.; Richter, Mark Nature Chemical Biology, Vol. 10, Issue 3 https://doi.org/10.1038/nchembio.1427	journal	January 2014
Non–lineage/stage-restricted effects of a gain-of-function mutation in tyrosine phosphatase Ptpn11 (Shp2) on malignant transformation of hematopoietic cells Xu, Dan; Liu, Xia; Yu, Wen-Mei Journal of Experimental Medicine, Vol. 208, Issue 10 https://doi.org/10.1084/jem.20110450	journal	September 2011
Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor Janes, Matthew R.; Zhang, Jingchuan; Li, Lian-Sheng Cell, Vol. 172, Issue 3 https://doi.org/10.1016/j.cell.2018.01.006	journal	January 2018
PD-1/SHP-2 Inhibits Tc1/Th1 Phenotypic Responses and the Activation of T Cells in the Tumor Microenvironment Li, J.; Jie, H. -B.; Lei, Y. Cancer Research, Vol. 75, Issue 3 https://doi.org/10.1158/0008-5472.can-14-1215	journal	December 2014
Optimization of Fused Bicyclic Allosteric SHP2 Inhibitors Bagdanoff, Jeffrey T.; Chen, Zhouliang; Acker, Michael Journal of Medicinal Chemistry, Vol. 62, Issue 4 https://doi.org/10.1021/acs.jmedchem.8b01725	journal	January 2019
Molecular Basis of Gain-of-Function LEOPARD Syndrome-Associated SHP2 Mutations Yu, Zhi-Hong; Zhang, Ruo-Yu; Walls, Chad D. Biochemistry, Vol. 53, Issue 25 https://doi.org/10.1021/bi5002695	journal	June 2014
Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2 Yokosuka, Tadashi; Takamatsu, Masako; Kobayashi-Imanishi, Wakana The Journal of Experimental Medicine, Vol. 209, Issue 6 https://doi.org/10.1084/jem.20112741	journal	May 2012
Allosteric inhibition of protein tyrosine phosphatase 1B Wiesmann, Christian; Barr, Kenneth J.; Kung, Jenny Nature Structural & Molecular Biology, Vol. 11, Issue 8 https://doi.org/10.1038/nsmb803	journal	July 2004
PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase Chan, Rebecca J.; Feng, Gen-Sheng Blood, Vol. 109, Issue 3 https://doi.org/10.1182/blood-2006-07-028829	journal	October 2006
Bedside to bench in juvenile myelomonocytic leukemia: insights into leukemogenesis from a rare pediatric leukemia Chang, Tiffany Y.; Dvorak, Christopher C.; Loh, Mignon L. Blood, Vol. 124, Issue 16 https://doi.org/10.1182/blood-2014-03-300319	journal	October 2014
The PDL1-PD1 Axis Converts Human T _H 1 Cells into Regulatory T Cells Amarnath, Shoba; Mangus, Courtney W.; Wang, James C. M. Science Translational Medicine, Vol. 3, Issue 111 https://doi.org/10.1126/scitranslmed.3003130	journal	November 2011
Activating Mutations of the Noonan Syndrome-Associated *SHP2/PTPN11* Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia Bentires-Alj, Mohamed; Paez, J. Guillermo; David, Frank S. Cancer Research, Vol. 64, Issue 24 https://doi.org/10.1158/0008-5472.can-04-1923	journal	December 2004
Protein tyrosine phosphatase SHP-2: A proto-oncogene product that promotes Ras activation Matozaki, Takashi; Murata, Yoji; Saito, Yasuyuki Cancer Science, Vol. 100, Issue 10 https://doi.org/10.1111/j.1349-7006.2009.01257.x	journal	October 2009
The role of Shp2 (PTPN11) in cancer Mohi, M. Golam; Neel, Benjamin G. Current Opinion in Genetics & Development, Vol. 17, Issue 1 https://doi.org/10.1016/j.gde.2006.12.011	journal	February 2007

Similar Records

Discovery of (3S,4S)-3-methyl-3-(4-fluorophenyl)-4-(4-(1,1,1,3,3,3-hexafluoro-2-hydroxyprop-2-yl)phe

Journal Article · Tue Sep 01 00:00:00 EDT 2020 · Bioorg. Med. Chem. Lett. · OSTI ID:1833652

Discovery of (3S,4S)-3-methyl-3-(4-fluorophenyl)-4-(4-(1,1,1,3,3,3-hexafluoro-2-hydroxyprop-2-yl)phe

Journal Article · Tue Sep 01 00:00:00 EDT 2020 · Bioorg. Med. Chem. Lett. · OSTI ID:1837292

Discovery of 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a Novel and Potent Vascular Endothelial Growth Factor Receptor Inhibitor

Journal Article · Tue Nov 19 23:00:00 EST 2013 · J. Med. Chem. · OSTI ID:1107387

Discovery of 6-[(3S,4S)-4-Amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-3-(2,3-dichlorophenyl)-2-m

Citation Formats

References (30)

Similar Records

Related Subjects